All the latest from Invest Liverpool
LSTM to head £2.7m infection diseases project
Liverpool School of Tropical Medicine
-
LSTM to head £2.7m infection diseases project
Liverpool School of Tropical Medicine (LSTM) is entering a new partnership to tackle infectious diseases killing millions of people across the world.
-
NEW LIVERPOOL SPINOUT ‘iiDIAGNOSTICS’ LAUNCHES TO SUPPORT WORLD-LEADING INDUSTRY/ACADEMIC CO-INNOVATION
Liverpool of Tropical Medicine (LSTM) has launched a spinout, iiDiagnostics, to enable industry engagement and commercial access to the world-leading diagnostics R&D capability and facilities at LSTM – supporting the discovery and development of innovative diagnostics to save lives globally.
-
WEBINAR: Understanding the Regulatory Landscape for Medical Devices and Diagnostics
iiCON: the Infection Innovation Consortium in collaboration with iiDiagnostics and QMS Consultancy are delighted to invite you to an online session.
-
Bill Gates puts his backing behind Liverpool City Region scientists in disease battle
Microsoft tycoon Bill Gates is backing scientists in Liverpool who have developed a new tool in the battle against deadly diseases such as malaria.
-
iiCON project leverages sensor technology for breakthrough diagnostic tool
iiCON (The Infection Innovation Consortium) is working with partners to develop a new non-invasive diagnostic tool that leverages sensor technology in the battle to eliminate some of the world’s deadliest vector-borne diseases, including Malaria and Visceral leishmaniasis.
-
Watch the Webinar: How businesses can access technical and specialist support in relation to infectious disease products
This webinar gives businesses information on how they can benefit from The Infection Innovation Consortium’s SME Support Programme (Formulated Materials for Infectious Disease Prevention).
-
LSTM AND iiCON SECURE FUNDING FOR NEXT-GENERATION HIGH-SECURITY LAB DEVELOPMENT
Liverpool School of Tropical Medicine (LSTM) and the Infection Innovation Consortium (iiCON) have secured a £500,000 grant that will support the development of new state-of-the-art Containment Level 3 laboratories at LSTM.
-
Liverpool City Region to become home to new global infection innovation hub
A new world-class multi-million pound facility, set to prepare public health experts and scientists for future health crises such as global pandemics is to open in Liverpool.
-
Liverpool agency Studio Coact appointed to deliver new infectious disease innovation and research website
The Infection Innovation Consortium (iiCON), a leading global centre of infectious disease innovation and R&D, has appointed the branding, web design, and digital marketing agency, Studio Coact, to deliver its new website following a competitive tender process.
-
IICON VALIDATED COVID TEST WILL SEE PRODUCT USED ACROSS AFRICA
A rapid COVID-19 antigen test, validated by researchers at Liverpool School of Tropical Medicine (LSTM) through the Infection Innovation Consortium (iiCON), will be used to deliver large-scale testing in key areas of need in Africa as part of a major FIND and UNITAID programme.